Miriam Monge Joins Sartorius Stedim Biotech - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Miriam Monge Joins Sartorius Stedim Biotech


Sartorius Stedim Biotech (SSB), an international pharma and biotech supplier, introduced on Aug. 26 Miriam Monge as director of marketing for SSB’s integrated solutions unit. Monge will focus on sharpening SSB’s profile as an integrated solution provider for the biopharmaceutical industry.

Monge has more than 20 years of experience in the biopharmaceutical manufacturing sector and served as vice president of sales and marketing at Biopharm Services. She is a committee member of the International Society for Pharmaceutical Engineering and one of the founders of the Global Disposable Community of Practice. She regularly authors articles for technical bioprocess journals, analyzing the impact of disposable technologies on biomanufacturing.

Source: Sartorius Stedim Biotech

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here